Phase II Study of KRP-209- A Double-Blind, Placebo-Controlled Clinical Trial to Evaluate Efficacy and Safety of KRP-209 in Patients with Subjective Tinnitus

Trial Profile

Phase II Study of KRP-209- A Double-Blind, Placebo-Controlled Clinical Trial to Evaluate Efficacy and Safety of KRP-209 in Patients with Subjective Tinnitus

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2017

At a glance

  • Drugs Neramexane (Primary)
  • Indications Tinnitus
  • Focus Therapeutic Use
  • Sponsors Kyorin Pharmaceutical
  • Most Recent Events

    • 06 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 02 Nov 2016 Status changed from recruiting to active, no longer recruiting.
    • 09 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top